#Marubeni

For the fiscal year ending March 2026, no shares were acquired with an acquisition amount of 0 yen. The board resolution sets an upper limit of 5 million shares and 15 billion yen.

Correction of an error in the approval procedure description in the notice of partial company split of the chemical business announced on February 12, 2026. The effective date is scheduled for April 1, 2026.

From February 5 to February 28, 2026, the treasury stock acquisition status was 0 shares acquired, with an acquisition cost of 0 yen. The Board of Directors resolved an acquisition limit of up to 5 million shares and 15 billion yen.

Effective April 1, 2026, Marubeni Corporation will transfer part of the Chemicals Division II business to its consolidated subsidiary Marubeni Chemix Corporation through a simplified absorption-type company split; on the same day, Marubeni Chemix will merge with Marubeni Plax and change its trade name to Marubeni Innovexis Corporation.

Revenue for the third quarter of the fiscal year ending March 2026 was 6,172.4 billion yen (up 7.9% YoY), operating income was 190.6 billion yen (down 14.3% YoY), and net income attributable to owners of parent for the quarter was 432.3 billion yen (up 1.7% YoY).

For the cumulative third quarter of the fiscal year ending March 2026, revenue was ¥6,172.4 billion (7.9% increase YoY), and net income attributable to owners of the parent for the quarter was ¥432.3 billion (1.9% increase YoY).

Marubeni Corporation has revised its annual dividend forecast per share for the fiscal year ending March 2026 from ¥100.00 to ¥107.50, and has also raised its year-end dividend forecast from ¥50.00 to ¥57.50 per share.

Marubeni Corporation has resolved to acquire up to 5 million shares of treasury stock (approximately 0.3% of issued shares) within a total purchase price limit of 15 billion yen, during the period from February 5, 2026 to June 30, 2026.

From January 1 to January 30, 2026, Marubeni Corporation acquired 3,996,000 shares of treasury stock totaling 19,687,315,200 yen, and completed the acquisition.

Marubeni Corporation plans to obtain approval at the Annual General Meeting of Shareholders scheduled for June 2026 to transition from a company with a board of statutory auditors to a company with a nomination committee, etc.

Marubeni Corporation plans to propose the transition to a company with a nominating committee system at the Annual General Meeting of Shareholders scheduled for June 2026, and has selected 15 director candidates. Personnel changes include 5 newly appointed director candidates.

An organizational restructuring will be implemented effective April 1, 2026, involving multiple department integrations, abolitions, and new establishments. Executive personnel changes, including the change of President and CEO, are planned after the annual shareholders meeting scheduled for June 2026.